CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-012408
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Prostaglandin reductase 1 
Protein Synonyms/Alias
 PRG-1; 15-oxoprostaglandin 13-reductase; NADP-dependent leukotriene B4 12-hydroxydehydrogenase 
Gene Name
 PTGR1 
Gene Synonyms/Alias
 LTB4DH 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
58RVAAKRLKEGDTMMGubiquitination[1]
70MMGQQVAKVVESKNVubiquitination[1]
178GAVGSDEKVAYLQKLubiquitination[1]
204ESLEETLKKASPDGYubiquitination[1]
289KALKDLLKWVLEGKIacetylation[2]
Reference
 [1] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [2] Regulation of cellular metabolism by protein lysine acetylation.
 Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, Guan KL.
 Science. 2010 Feb 19;327(5968):1000-4. [PMID: 20167786
Functional Description
 Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4. 
Sequence Annotation
 NP_BIND 152 155 NADP.
 NP_BIND 239 245 NADP.
 NP_BIND 270 272 NADP.
 BINDING 178 178 NADP.
 BINDING 193 193 NADP.
 BINDING 217 217 NADP.
 BINDING 321 321 NADP.  
Keyword
 3D-structure; Alternative splicing; Complete proteome; Cytoplasm; NADP; Oxidoreductase; Polymorphism; Reference proteome. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 329 AA 
Protein Sequence
MVRTKTWTLK KHFVGYPTNS DFELKTAELP PLKNGEVLLE ALFLTVDPYM RVAAKRLKEG 60
DTMMGQQVAK VVESKNVALP KGTIVLASPG WTTHSISDGK DLEKLLTEWP DTIPLSLALG 120
TVGMPGLTAY FGLLEICGVK GGETVMVNAA AGAVGSVVGQ IAKLKGCKVV GAVGSDEKVA 180
YLQKLGFDVV FNYKTVESLE ETLKKASPDG YDCYFDNVGG EFSNTVIGQM KKFGRIAICG 240
AISTYNRTGP LPPGPPPEIV IYQELRMEAF VVYRWQGDAR QKALKDLLKW VLEGKIQYKE 300
YIIEGFENMP AAFMGMLKGD NLGKTIVKA 329 
Gene Ontology
 GO:0005737; C:cytoplasm; NAS:UniProtKB.
 GO:0036132; F:13-prostaglandin reductase activity; IEA:EC.
 GO:0047522; F:15-oxoprostaglandin 13-oxidase activity; IEA:EC.
 GO:0032440; F:2-alkenal reductase [NAD(P)] activity; IEA:EC.
 GO:0004022; F:alcohol dehydrogenase (NAD) activity; NAS:UniProtKB.
 GO:0008270; F:zinc ion binding; IEA:InterPro.
 GO:0019371; P:cyclooxygenase pathway; TAS:Reactome.
 GO:0006691; P:leukotriene metabolic process; NAS:UniProtKB.
 GO:2001300; P:lipoxin metabolic process; TAS:Reactome.
 GO:0009636; P:response to toxic substance; IEA:Compara. 
Interpro
 IPR013149; ADH_C.
 IPR002085; ADH_SF_Zn-type.
 IPR014190; B4_12hDH.
 IPR011032; GroES-like.
 IPR016040; NAD(P)-bd_dom. 
Pfam
 PF00107; ADH_zinc_N 
SMART
  
PROSITE
  
PRINTS